注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
ChromaDex Corp是一家全球生物科學公司,從事煙酰胺腺嘌呤二核苷酸(NAD+)的研究,其水平隨著年齡的增長而下降。NAD+是一種輔酶,是細胞代謝的調節劑。該公司通過三個分部運營:消費品分部、配料分部以及分析參考標準和服務分部。消費品分部直接向消費者和分銷商提供含有這些成分的成品膳食補充劑。配料分部開發和商業化配料技術,並將這些配料作為原材料供應給消費品製造商。分析參考標準和服務分部提供植物化學參考標準和其他研發服務。其成分包括Tru Niagen和Immulina。Tru Niagen是煙酰胺核糖(NR)的一種形式。NR是維生素B3家族的一員。Immulina是一種螺旋藻提取物。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Charles Brenner | - | 2014 | Chief Scientific Advisor & Member of Scientific Advisory Board |
Frank Louis Jaksch | 55 | 1999 | Co-Founder & Chairman |
John Walker | - | 2018 | Member of Scientific Advisory Board |
Wing Tak Yu | 47 | 2017 | Non-Executive Director |
Steven D. Rubin | 63 | 2017 | Lead Independent Director |
J. Bruce German | - | 2014 | Member of Scientific Advisory Board |
Robert N. Fried | 63 | 2015 | CEO & Director |
Roger D. Kornberg | 76 | 2014 | Chairman of the Scientific Advisory Board |
Brunie H. Felding | - | 2019 | Member of the Scientific Advisory Board |
Rudolph Emile Tanzi | 64 | 2017 | Member of Scientific Advisory Board |
David L. Katz | 59 | 2021 | Member of Scientific Advisory Board |
Kristin Patrick | 52 | 2022 | Independent Director |
Wang Yu Ng | 51 | 2021 | Non-Executive Director |
Ann Cohen | 62 | 2022 | Independent Director |
Vilhelm Bohr | - | 2023 | Member of Scientific Advisory Board |
Hamed Shahbazi | 48 | 2022 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核